MedTrace Logo

Kinematics and Muscle Strength in Two, Five or 10 Years Afther Total Hip Arthroplasty

NCT04214171 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-09-09

No results posted yet for this study

Summary

Introduction: Femoral and acetabular replacement is characterized as total hip arthroplasty (THA). It has been used as treatment of various pathologies of this joint. In the postoperative period, some studies have shown that strength, function, range of motion and lower limb mechanics remains altered for more than One year after THA in relation to the non-operated side. However, studies that have correlated kinematics and hip muscle strength in individuals who underwent THA for long time, do not exist in literature. Objective: to evaluate lower limb muscle strength and 2D kinematics during stair ascending and descending in patients undergoing total hip arthroplasty. Methods: Third individuals who underwent total hip arthroplasty (THA) will be recruited at two, five and 10 year postoperative periods. They were allocated in three groups: Group 1 (10n), subjects submitted to THA for two years, Group 2 (10n) subjects submitted to THA for five years, Group 3 (10n) subjects submitted to THA for 10 years and Group 4 (10n) subjects without orthopaedic afections, all will be evaluated for dynamometric isometric muscle strength and kinematic analysis of stair ascending and descending by a "blinded" physical Therapist.

Conditions

  • Hip Osteoarthritis

Interventions

DIAGNOSTIC_TEST

Gait and muscle strength will be assessed

The extensor moment of the hip during gait and evaluation of the muscular strength of the hip will be evaluated

Sponsors & Collaborators

  • Faculdade de Ciências Médicas da Santa Casa de São Paulo

    lead OTHER

Principal Investigators

  • Vera Lucia Santos Alves, Dr · Faculdade de Ciências Médicas da Santa Casa de São Paulo

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-09-01
Completion
2019-02-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04214171 on ClinicalTrials.gov